ERBB2 and neoplasm: Currently, tumour biopsy samples are needed for the determination of HER2 status since immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are the only methods recommended by the American Society of Clinical Oncology and College of American Pathologists (ASCO/CAP, 2018) [4].